Belimumab in Remission of VASculitis (BREVAS)
This study is not yet open for participant recruitment.
Verified January 2013 by GlaxoSmithKline
Sponsor:
Human Genome Sciences Inc., a GSK Company
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
GlaxoSmithKline ( Human Genome Sciences Inc., a GSK Company )
ClinicalTrials.gov Identifier:
NCT01663623
First received: August 9, 2012
Last updated: February 7, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | August 2016 |
| Estimated Primary Completion Date: | December 2015 (Final data collection date for primary outcome measure) |